Orchard Therapeutics plc

Orchard Therapeutics plc, headquartered in Great Britain, currently does not have available emissions data for the most recent year, as indicated by the absence of specific figures. The company is a current subsidiary of Kyowa Kirin Co., Ltd., which may influence its climate commitments and emissions reporting.

While no specific reduction targets or achievements are listed for Orchard Therapeutics, it is important to note that the company is part of a corporate family that includes Kirin Holdings Company, Limited. This relationship may provide a framework for climate initiatives, as Kirin Holdings is involved in various sustainability efforts, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP).

As a subsidiary, Orchard Therapeutics may align its climate strategies with those of its parent company, which could include commitments to reduce carbon emissions and improve sustainability practices. However, without specific emissions data or reduction targets from Orchard Therapeutics itself, a detailed assessment of its carbon footprint and climate commitments remains unavailable.